Stuart Curbishley

Chief Manufacturing & Development Officer • adthera bio

Stuart was awarded his PhD by the University of Birmingham in 2005 after which his group developed a programme of early-phase clinical trials, leading the development of dendritic cell therapy for primary liver cancer. Stuart directed the University of Birmingham’s GMP manufacturing unit, overseeing the development of new ATMPs, extending to T cell products, stromal cells, chondrocytes, and dendritic cells. Now playing a leading role in developing Adthera bio, Stuart brings his expertise in closing manufacturing processes and developing sustainable, scalable solutions to the projects his team work on.

Also speaking

Martin Bornhauser

Professor, Head of the Department for Hematology and Medical Oncology • University Hospital Dresden

Matthew Lakelin

Vice President, Scientific Affairs & Product Development, Co-Founder • Trakcel

Elsa Abranches

Senior Director, Head of Cell Therapy Bioprocess Development and Manufacturing, BioPharmaceuticals R&D • AstraZeneca

Event Info


2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.

Innovation Zone

Find out more about the Innovation Zone at Advanced Therapies Europe.